Turning numbers into action: optimising care in T2DM and CKD
16 Oct 2024
Future of Diabetes Care Theatre
)
This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
This session will be a ‘how-to’ guide for interpreting clinical trials. The objectives are to:
- Focus on risk-based data reported in clinical trials and what it means to your clinical practice
- Understand the statistics of trials so you can identify opportunities to manage cardiorenal risks in line with NICE recommendations
Throughout the session, an AstraZeneca medicine and associated clinical trial will be discussed.
GB-58815, DOP: Sept 2024
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}
.jpg/fit-in/1280x9999/filters:no_upscale()){kind=logo}
.png/fit-in/1280x9999/filters:no_upscale())
)
){kind=logo}
){kind=logo}
